Pfizer stock forecasts, price predictions & targets for 2024-2030

Pfizer is one of the world’s largest and best known pharmaceutical companies. Use this guide to find out the latest Pfizer stock price forecasts.
Updated: Oct 30, 2023

The average Pfizer stock forecast is $40.86. This is based on 15 Wall Street analysts offering Pfizer price targets and guidance for the next 12 months. The maximum Pfizer price prediction is $75, while the minimum forecast is $33.

Read on for a detailed breakdown of Pfizer stock forecasts for 2024 and beyond.

PFE stock forecast & price target

Copy link to section

The majority of analysts are of the opinion that holding Pfizer shares is the best option. Most expect its price to rise, although how much upside potential it has is up for debate. The highest PFE stock price forecast comes in at $76, while the lowest is $35. Below we’ve summarised the latest Pfizer stock price predictions and provided an average.

The table below provides a short summary of Pfizer stock forecasts for the next decade. These are based on a combination of analyst ratings and Pfizer maintaining its average annual growth rate of 7.07% over the last 10 years.

YearPfizer stock forecastChange (%)
Pfizer stock forecasts based on average annual growth rate, updated June 2024

Expert forecasts on the future of Pfizer (PFE)

Copy link to section

Analysts from major investment firms regularly offer comment and guidance about the biggest stocks to their clients. Generally, each analyst updates their guidance every few months, providing a price target and a BUY, SELL, or HOLD rating based on their level of confidence.

Here are some of the latest price targets and Pfizer guidance from leading professional investors.

Stock analystPfizer price targetGuidance
Cantor Fitzgerald$75BUY
Berenberg Bank$35HOLD
Redburn Atlantic$46HOLD
Credit Suisse$42HOLD
UBS Group$34HOLD
Truist Financial$42BUY
Morgan Stanley$39EQUAL WEIGHT
BMO Capital Markets$33OUTPERFORM
J.P. Morgan$34HOLD
Wells Fargo$35EQUAL WEIGHT
Analyst price targets for Pfizer stock, updated June 2024

Below you will find a selection of quotes from the most prominent expert opinions on the future of the stock, helping you gain an insight into what the analysts think.

Our views on Pfizer come down to that we estimate around one-third of its current valuation is attributed to the COVID-19 vaccine and therapeutic and we feel the trajectory for both remains highly uncertain.

Chris Shibutani, Goldman Sachs, $51 price target

With an implied core multiple already well above peers facing mid- to late-decade patent expirations , we see PFE shares as fully valued at current levels and believe it is unlikely vaccine upside alone can drive shares meaningfully above current levels”

Chris Schott. JP Morgan, $57 price target

Short term PFE forecast

Copy link to section

In the short term the consensus estimate is that Pfizer’s stock price may see little movement. The pandemic and subsequent vaccine helped push the company’s share price much higher and analysts believe it will likely stay flat.

This is the latest Pfizer stock sentiment for the next month, based on a range of technical indicators including trading volume, moving averages, and oscillators.

This graphic is merely a representation of the latest technical analysis and does not constitute financial advice.

Below is a summary of some expert Pfizer stock price forecasts for the next two years.

Pfizer stock price prediction 2023

Copy link to section

In 2023 Pfizer’s stock price could reach $44.00 That is the average Pfizer stock price forecast from a selection of analysts that have provided ratings for the company. T If it does get there, it will still have some way to go before it can reach its all-time high set in late 2021 at $61.71.

Pfizer Inc. price prediction 2024

Copy link to section

PFE’s stock price could be trading at $70 in 2024. That price is inline with analysts at Bank of America who have a buy rating for the company. 

Long term PFE forecast

Copy link to section

Most experts tend not to provide long term forecasts, however for large companies like Pfizer, some have. Below is a summary of Pfizer stock price forecasts for the remainder of the decade. It’s important to note that longer term predictions are more speculative in nature. 

Pfizer price prediction 2025

Copy link to section

In 2025 Pfizer’s stock price is forecast to be between $70 – $90. The most bullish price forecast is $76 from BMO Capital Markets, although other analysts expect strong momentum from the company within the next several years. 

Pfizer price prediction 2030

Copy link to section

Some experts have suggested that Pfizer’s stock could break above $100 by the end of the decade. However, a lot needs to fall into place between now and then for its stock price to hit triple digits. 

Compare the best places to buy Pfizer stock

Copy link to section

If you agree with the experts and want to buy some Pfizer shares you’ll need to use an online broker to do so. Check out the table below which includes a list of the best brokers around for buying PFE stock. Click on any of the links to get started in just a few minutes.

Sort by:

Min. Deposit
$ 0
Best offer
User Score
TastyTrade allows you to buy and sell U.S. stocks without paying any commission fees.
Whether you’re a short-term trader or a long-term investor, TastyTrade accommodates various investment horizons.
Explore over 8,000 U.S. stocks and consider exchange-traded funds (ETFs) for broader exposure to the market.
Start Trading
Payment Methods:
Wire Transfer, Check, ACH
Full Regulations:
Min. Deposit
$ 100
Best offer
User Score
Trade +2000 CFDs on Shares, Options, Commodities & more
Unlimited risk-free Demo Account
0 commissions & attractive spreads with up to 1:5 leverage
Start Trading
Payment Methods:
Bank Transfer, Debit Card, PayPal, Credit Card, Visa, Mastercard, American Express, Trustly, Apple Pay, Google Pay, Discover, Bank Transfer: SEPA, Bank Transfer: FPS, skrill
Full Regulations:
ASIC, FCA, FSA, MAS, CySEC #250/14

CFD service. 82% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

Min. Deposit
$ 0
Best offer
User Score
Allows commission-free trading of individual stocks and over 2,000 ETFs.
TradeStation’s platform supports options, futures, and futures options trading.
Traders benefit from award-winning software with advanced analysis capabilities and customization options.
Start Trading
Payment Methods:
Wire Transfer, Check, ACH
Full Regulations:

What affects the price of PFE?

Copy link to section

Pfizer Inc. is one of the largest pharmaceutical companies in the world so it’s little surprise that medicines and vaccines are key drivers in its performance. There are also a range of other factors such as, pipeline updates, merger activity, dividends, and overall market sentiment, that impact its stock price and below, we’ve briefly explained a few of the top ones. 

  • Medicines and vaccines. During the pandemic, Pfizer Inc. became somewhat of a household name when it delivered a COVID-19 vaccine. However, it’s not just vaccines it develops and medicines are a large part of its revenue. Its ability to create new medicines will be reflected in its share price. 
  • Covid. In 2021 Pfizer made $37 billion from its Covid vaccine. Thanks to the jab, its revenue doubled to over $80 billion from 2020. It’s in the process of developing a Covid pill which it expects will add to sales. Any new COVID variants will likely be positive for the company, which is one of the world’s few covid19 vaccine suppliers. 
  • Competition. The pharmaceutical industry is massive and has lots of key players operating within it. Pfizer has stiff competition from the likes of Roche, Eli Lilly, Abbvie, and Novartis. These companies develop similar drugs to that of Pfizer Inc. and the race to cure illnesses like cancer between the businesses is ongoing. 
  • Financial performance. Pfizer’s earnings results each quarter significantly impact PFE’s current price. Strong revenue and earnings growth that exceeds market averages and analyst estimates will lift the stock, while underperformance drags shares lower. Sales trends for key drugs like Paxlovid also move Pfizer share price.
  • Pipeline progress. Advancements in Pfizer’s drug development pipeline, positive clinical trial data, regulatory approvals, and launches of new therapies also affect the stock. Setbacks like failed studies or rejections can negatively impact shares.
  • Analyst sentiment. Analyst ratings and price targets influence Pfizer’s valuation. Multiple upgrades or downgrades, especially from top firms, can swing PFE’s last price higher or lower. The average price target relative to the current level indicates the expected upside/downside.
  • Mergers & acquisitions. Pfizer frequently engages in major M&A deals. Acquisitions and partnerships that expand Pfizer’s drug portfolio or add promising drug candidates tend to lift the stock. Meanwhile, failed deals can weigh on shares.
  • Dividend changes. As a dividend paying stock, PFE’s attractive and growing quarterly dividend impacts some investor demand. Changes in the payout amount or reductions would likely impact the stock price.

How has the Pfizer price changed over time?

Copy link to section

It’s been a strong performer for the past decade or so. Since 2009 its stock price has been on a steady incline and has increased by over 400%. Unsurprisingly, the past couple of years have been extremely good for the company. Following its development and release of its Covid19 vaccine, shares in the company have more than doubled. 

What should I do now?

Copy link to section

Now that you have some expert opinions and forecasts on Pfizer shares you may want to consider buying shares in the company. To do so you’ll need to register with an online brokerage firm. Alternatively to learn more about the stock market you can check out our hub page with free courses. Whatever you decide, it’s a good idea to keep up to date with the latest news and market analysis, which you can do so by the links below.

Register and buy Pfizer stock

Latest Pfizer news

Copy link to section
Why is Pfizer stock being punished this morning?
Pfizer Inc (NYSE: PFE) opened about 9.0% down on Wednesday after its management issued guidance for the coming year that fell short of Street estimates. Pfizer’s earnings and revenue outlook for 2024 The pharmaceutical behemoth forecasts its revenue to be in the range of $58.5 billion and $61.5 bill
Eli Lilly, Novo Nordisk to benefit as Pfizer’s weight loss drug implodes
Eli Lilly (NYSE: LLY) and Novo Nordisk NYSE: NVO) stock prices have been some of the hottest names in Wall Street. NVO has soared by over 48% this year while LLY has surged by over 61%. In total, these companies are now valued at almost $1 trillion. Eli Lilly and Novo Nordisk have become well-known
Pfizer stock dips as Swiss Biotech Basilea secures rights to Fosmanogepix
Swiss biotech Basilea Pharmaceutica (OTC:BPMUF) and Pfizer (NYSE:PFE) subsidiary Amplyx Pharmaceuticals have inked a deal worth $37 million, granting Basilea rights to Fosmanogepix, a Phase 3 ready broad-spectrum antifungal. The agreement, announced on Monday, marks a strategic move in the pharmaceu

Sources & references
Risk disclaimer
Prash Raval
Financial Writer
Prash is a financial writer for Invezz covering FX, the stock market and investing. For over a decade he has traded spot FX full time while... read more.